"9-1-1: Nashville" is continuing to build out its cast, with the upcoming ABC drama adding four new cast members.

Sanofi is set to acquire Blueprint Medicines for $9.1 billion, strengthening its immunology portfolio with the addition of Ayvakit/Ayvakyt, a drug for systemic mastocytosis. The acquisition also ...